News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,155 Results
Type
Article (14173)
Company Profile (282)
Press Release (251700)
Section
Business (79492)
Career Advice (153)
Deals (13224)
Drug Delivery (35)
Drug Development (50433)
Employer Resources (31)
FDA (5711)
Job Trends (5127)
News (144362)
Policy (10028)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (910)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21632)
ALS (59)
Alzheimer's disease (820)
Antibody-drug conjugate (ADC) (82)
Approvals (5720)
Artificial intelligence (104)
Autoimmune disease (10)
Automation (5)
Bankruptcy (104)
Best Places to Work (4560)
BIOSECURE Act (5)
Biosimilars (38)
Biotechnology (232)
Bladder cancer (42)
Brain cancer (19)
Breast cancer (137)
Cancer (1249)
Cardiovascular disease (100)
Career advice (132)
Career pathing (2)
CAR-T (107)
Cell therapy (302)
Cervical cancer (6)
Clinical research (40810)
Collaboration (491)
Compensation (216)
Complete response letters (13)
COVID-19 (1031)
CRISPR (36)
C-suite (137)
Cystic fibrosis (75)
Data (1287)
Denatured (11)
Depression (28)
Diabetes (122)
Diagnostics (1290)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (76)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (77)
Earnings (29558)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48042)
Executive appointments (396)
FDA (6307)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (457)
Gene editing (86)
Generative AI (9)
Gene therapy (224)
GLP-1 (350)
Government (1074)
Grass and pollen (2)
Guidances (18)
Healthcare (6585)
Huntington's disease (21)
IgA nephropathy (19)
Immunology and inflammation (78)
Indications (18)
Infectious disease (1089)
Inflammatory bowel disease (109)
Inflation Reduction Act (8)
Influenza (17)
Intellectual property (54)
Interviews (17)
IPO (7261)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (199)
Leadership (2)
Legal (1386)
Liver cancer (30)
Lung cancer (176)
Lymphoma (81)
Machine learning (1)
Management (7)
Manufacturing (113)
MASH (46)
Medical device (2586)
Medtech (2587)
Mergers & acquisitions (6245)
Metabolic disorders (356)
Multiple sclerosis (50)
NASH (13)
Neurodegenerative disease (55)
Neuropsychiatric disorders (23)
Neuroscience (1178)
NextGen: Class of 2025 (2016)
Non-profit (852)
Northern California (1499)
Now hiring (21)
Obesity (183)
Opinion (100)
Ovarian cancer (57)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (102)
Partnered (6)
Patents (105)
Patient recruitment (64)
Peanut (35)
People (25472)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14410)
Phase II (18985)
Phase III (12002)
Pipeline (635)
Podcasts (45)
Policy (34)
Postmarket research (852)
Preclinical (6042)
Press Release (30)
Prostate cancer (51)
Psychedelics (35)
Radiopharmaceuticals (211)
Rare diseases (267)
Real estate (1414)
Recruiting (12)
Regulatory (8527)
Reports (15)
Research institute (937)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (54)
Series A (89)
Series B (57)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1329)
Special edition (11)
Spinal muscular atrophy (116)
Sponsored (11)
Startups (1971)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (33)
United States (11804)
Vaccines (203)
Venture capitalists (28)
Webinars (7)
Weight loss (103)
Women's health (15)
Worklife (2)
Date
Today (81)
Last 7 days (343)
Last 30 days (1686)
Last 365 days (20069)
2025 (4331)
2024 (20552)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11740)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (38)
Alaska (2)
Arizona (51)
Arkansas (5)
Asia (17186)
Australia (2913)
California (3423)
Canada (1036)
China (308)
Colorado (130)
Connecticut (141)
Delaware (86)
Europe (36975)
Florida (399)
Georgia (104)
Idaho (16)
Illinois (208)
India (7)
Indiana (85)
Iowa (1)
Japan (66)
Kansas (58)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (438)
Massachusetts (2708)
Michigan (69)
Minnesota (133)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (13)
New Jersey (855)
New Mexico (12)
New York (941)
North Carolina (511)
North Dakota (4)
Northern California (1499)
Ohio (107)
Oklahoma (9)
Oregon (21)
Pennsylvania (650)
Puerto Rico (3)
Rhode Island (14)
South America (208)
South Carolina (4)
Southern California (1329)
Tennessee (25)
Texas (386)
Utah (48)
Virginia (66)
Washington D.C. (28)
Washington State (315)
Wisconsin (13)
266,155 Results for "aligos therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aligos Therapeutics Announces $105 Million Private Placement Financing
February 12, 2025
·
5 min read
Press Releases
Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025
March 3, 2025
·
2 min read
Press Releases
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results
March 10, 2025
·
12 min read
Press Releases
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 14, 2025
March 17, 2025
·
2 min read
Press Releases
Aligos Therapeutics to Present at Investor Conferences in December
November 26, 2024
·
2 min read
MASH
Aligos Claims Mid-Stage Win in MASH but Investors Are Skeptical
An unusual placebo effect in Aligos Therapeutics’ Phase IIa trial is driving shareholder skepticism for its metabolic dysfunction-associated steatohepatitis candidate, according to Jefferies analyst Michael Yee.
September 20, 2024
·
2 min read
·
Tristan Manalac
Biotech Bay
Aligos Therapeutics Presents Positive Data at the EASL Congress 2024
Aligos Therapeutics, Inc. announced positive data from six poster presentations at the European Association for the Study of the Liver Congress 2024, being held June 5-8 in Milan, Italy.
June 5, 2024
·
5 min read
Press Releases
Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024
November 19, 2024
·
7 min read
Press Releases
Aligos Therapeutics to Present at Investor Conferences in October
September 30, 2024
·
2 min read
Business
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
Aligos Therapeutics, Inc. reported recent business progress and financial results for the first quarter 2024.
May 7, 2024
·
9 min read
1 of 26,616
Next
